AIS/BPAX - I've been a long-time investor in AIS & think it has a lot of potential to move higher. Partnership possibilities for Libigel, Anturol, Nestorone, and their methotrexate injector could all add substantial value.
My biggest concern with BPAX is the handling of the data collection for the libigel trial. Could it be another SQNM?